Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


Safety and effectiveness of erenumab in chronic refractory migraine

  • At: Virtual 2020 (2020)
  • Type: Poster
  • Poster code: POS-HPS-003
  • By: ALONSO PERALTA, Carlos Angel (Hospital Universitario Marqués de Valdecilla, Hospital pharmacy, Spain)
  • Co-author(s): Maria Rioja Carrera: Hospital pharmacy, Hospital Universitario Marqués de valdecilla, Santander, Spain
    Julia Sánchez Gundín: Hospital pharmacy, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Berta Rogado Vegas: Hospital pharmacy, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Carlos Angel Alonso Peralta: Hospital pharmacy, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Paula del Rio Ortega: Hospital pharmacy, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Juan Casanova Vázquez: Hospital pharmacy, Hospital Universitario Marqués de Valdecilla, Santander, Spain
    Marta Valero Dominguéz: Hospital pharmacy, Hospital Universitario Marqués de Valdecilla, Santander, Spain
  • Abstract:

    Background

    Erenumab is a human monoclonal antibody that inhibits the peptide receptor related to the calcitonin gene, a vasodilator associated with the physiopathology of migraine.

    Purpose

    To evaluate the effectiveness and safety of erenumab in chronic migraine of ≥8 days/month, with previous failure to 3 or more drugs, including botulinum toxin.

    Me

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses